Literature DB >> 23948218

Developing 'integrative' zebrafish models of behavioral and metabolic disorders.

Michael Nguyen1, Ester Yang, Nikhil Neelkantan, Alina Mikhaylova, Raymond Arnold, Manoj K Poudel, Adam Michael Stewart, Allan V Kalueff.   

Abstract

Recently, the pathophysiological overlap between metabolic and mental disorders has received increased recognition. Zebrafish (Danio rerio) are rapidly becoming a popular model organism for translational biomedical research due to their genetic tractability, low cost, quick reproductive cycle, and ease of behavioral, pharmacological or genetic manipulation. High homology to mammalian physiology and the availability of well-developed assays also make the zebrafish an attractive organism for studying human disorders. Zebrafish neurobehavioral and endocrine phenotypes show promise for the use of zebrafish in studies of stress, obesity and related behavioral and metabolic disorders. Here, we discuss the parallels between zebrafish and other model species in stress and obesity physiology, as well as outline the available zebrafish models of weight gain, metabolic deficits, feeding, stress, anxiety and related behavioral disorders. Overall, zebrafish demonstrate a strong potential for modeling human behavioral and metabolic disorders, and their comorbidity.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Comorbidity; Metabolic disorders; Neurobehavioral disorders; Obesity; Stress; Zebrafish models

Mesh:

Year:  2013        PMID: 23948218     DOI: 10.1016/j.bbr.2013.08.012

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  16 in total

Review 1.  Zebrafish as an emerging model for studying complex brain disorders.

Authors:  Allan V Kalueff; Adam Michael Stewart; Robert Gerlai
Journal:  Trends Pharmacol Sci       Date:  2014-01-09       Impact factor: 14.819

Review 2.  Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System.

Authors:  Nithya Srinivas; Kaitlyn Maffuid; Angela D M Kashuba
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

3.  Obesity-induced decreases in muscle performance are not reversed by weight loss.

Authors:  F Seebacher; J Tallis; K McShea; R S James
Journal:  Int J Obes (Lond)       Date:  2017-03-24       Impact factor: 5.095

4.  Determination of narcotic potency using a neurobehavioral assay with larval zebrafish.

Authors:  Harry W Broening; Jane La Du; Gregory J Carr; J F Nash; Lisa Truong; Robert L Tanguay
Journal:  Neurotoxicology       Date:  2019-05-11       Impact factor: 4.294

5.  Unpredictable Chronic Stress Alters Adenosine Metabolism in Zebrafish Brain.

Authors:  F F Zimmermann; S Altenhofen; L W Kist; C E Leite; M R Bogo; G P Cognato; C D Bonan
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

Review 6.  Diabetes, adult neurogenesis and brain remodeling: New insights from rodent and zebrafish models.

Authors:  Anne-Claire Dorsemans; David Couret; Anaïs Hoarau; Olivier Meilhac; Christian Lefebvre d'Hellencourt; Nicolas Diotel
Journal:  Neurogenesis (Austin)       Date:  2017-01-31

Review 7.  Zebrafish models for translational neuroscience research: from tank to bedside.

Authors:  Adam Michael Stewart; Oliver Braubach; Jan Spitsbergen; Robert Gerlai; Allan V Kalueff
Journal:  Trends Neurosci       Date:  2014-04-09       Impact factor: 13.837

8.  Adult zebrafish in CNS disease modeling: a tank that's half-full, not half-empty, and still filling.

Authors:  Darya A Meshalkina; Elana V Kysil; Jason E Warnick; Konstantin A Demin; Allan V Kalueff
Journal:  Lab Anim (NY)       Date:  2017-10-06       Impact factor: 12.625

9.  Working with zebrafish at postembryonic stages.

Authors:  S K McMenamin; M N Chandless; D M Parichy
Journal:  Methods Cell Biol       Date:  2016-02-28       Impact factor: 1.441

10.  The Effects of Chronic Amitriptyline on Zebrafish Behavior and Monoamine Neurochemistry.

Authors:  Darya A Meshalkina; Elana V Kysil; Kristina A Antonova; Konstantin A Demin; Tatiana O Kolesnikova; Sergey L Khatsko; Raul R Gainetdinov; Polina A Alekseeva; Allan V Kalueff
Journal:  Neurochem Res       Date:  2018-05-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.